Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA

Transplantation

Volumn 95, Issue 5, 2013, Pages 701-704

  Zachary, Andrea A ^a   Lucas, Donna P ^a   Montgomery, Robert A ^a   Leffell, Mary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anamnestic response; HLA antibody; Rituximab; Sensitization

Indexed keywords

HLA ANTIGEN; HLA B7 ANTIGEN; RITUXIMAB; TETRAMER; ALLOANTIBODY; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; HLA MATCHING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIZATION; STAINING; BLOOD; HISTOCOMPATIBILITY; IMMUNOLOGY; PROTEIN MULTIMERIZATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; B-LYMPHOCYTES; HLA ANTIGENS; HUMANS; ISOANTIBODIES; PROTEIN MULTIMERIZATION; TRANSPLANTATION IMMUNOLOGY;

MLCS; MLOWN;

EID: 84877280405     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827be3c1     Document Type: Article

References (22)

1. Marfo K, Lu A, Ling M, et al. Desensitization protocols and their outcome. Clin J Am Soc Nephrol 2011; 6: 922.
2. Leffell MS, Zachary AA. Antiallograft antibodies: relevance, detection, and monitoring. Curr Opin Organ Transplant 2010; 15: 2.
3. Zachary AA, Sholander JT, Houp JA, et al. Using real data for a virtual crossmatch. Hum Immunol 2009; 70: 574.
4. Tait BD. Solid phase assays for HLA antibody detection in clinical transplantation. Curr Opin Immunol 2009; 21: 573.
5. Van den Hoogen MW, Hilbrands LB. Use of monoclonal antibodies in renal transplantation. Immunotherapy 2011; 3: 871.
6. Li X, Ishida H, Yamaguchi Y, et al. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Transpl Int 2008; 21: 1145.
7. Smith JD, Banner NR, Hamour IM, et al. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011; 11: 312.
8. Spriewald BM, Hugo C. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection. In: PI Terasaki, ed. Clinical transplants. Los Angeles, Terasaki Foundation Laboratory 2007, p. 469.
9. Lanzavecchia A, Sallusto F. Human B cell memory. Cur Opin Immunol 2009; 21: 298.
10. Zachary AA, Kopchaliiska D, Montgomery RA, et al. HLA-specific B cells. I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007; 83: 982.
11. Good KL, Avery DT, Tangye SG. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009; 182: 890.
12. Zachary AA, Kopchaliiska D, Montgomery RA, et al. HLA-specific B cells. II. Application to transplantation. Transplantation 2007; 83: 989.
13. Genberg H, Hansson A, Wernerson A, et al. Pharmacodynamics of rituximab in kidney transplantation. Transplantation 2007; 84: S33.
14. Ramos EJ, Pollinger HS, Stegall MD, et al. The effect of desensitization protocols on human splenic B-cell populations in vivo. Am J Transplant 2007; 7: 402.
15. Puissant-Lubrano B, Rostaing L, Kamar N, et al. Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney transplant patients. Exp Clin Transplant 2010; 8: 19.
16. Kohei N, Hirai T, Omoto K, et al. Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period. Am J Transplant 2012; 12: 469.
17. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359: 242.
18. Kranz B, Kelsch R, Kuwertz-Bröking E, et al. Acute antibody-mediated rejection in paediatric renal transplant recipients. Pediatr Nephrol 2011; 26: 1149.
19. Uchida J, Machida Y, Iwai T, et al. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation. Transplant Proc 2010; 42: 3998.
20. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sen-sitization lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54.
21. Hodges AM, Lyster H, McDermott A, et al. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody. Transplantation 2012; 93: 650.
22. Hirai T, Ishida H, Toki D, et al. Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy. Ther Apher Dial 2011; 15: 89.